Futuristic Solutions Limited

Financial Services — Credit Services · BSE

₹45.28₹0.00 (0.00%)

DalalBaazaar Score

63 / 100

🟢 Good

Verdict

REASONABLE

Risk

Moderate

Driven by micro-cap size, which brings thin liquidity.

In simple words: The business is earning a fairly low return on the money invested in it, with both sales and profits growing well. Nothing on this snapshot stands out as an immediate concern — the usual checks on business quality and management still apply.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 8:26 pm

Understanding the Business

Company site ↗

The 60-second version of Futuristic Solutions Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Futuristic Solutions Limited engages in the provision of futuristic solutions of arbitration cases and recovery of disputed debts in India.

IndustryCredit Services

SectorFinancial Services

Employees3

Annual revenue₹7 Cr

How does it make money?

Turns over ₹7 Cr a year. Of every ₹100 of sales, about ₹12 reaches shareholders as profit, with ₹26 left at the operating level before interest, tax and depreciation. Each of its 3 employees supports ₹2.17 Cr of revenue a year, the signature of a capital- or asset-led business.

Revenue / employee₹2.17 Cr

Who are its competitors?

The closest listed comparisons in its industry are BAJAJ FINANCE LIMITED, STATE BANK OF INDIA, HDFC BANK LTD, ICICI BANK LTD.. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?Not assessable from these ratios

For a lender, returns on capital are shaped by leverage and funding cost rather than by pricing power, so the usual financial signature of an advantage does not apply. Judge this one on deposit franchise, cost of funds and asset quality — none of which are in this data.

Peer median ROE16.5%

What has been driving growth?

Sales and margins have both contributed to where profit is now. Over 3 years revenue moved +83% while net margin moved -84% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+83%

Margin effect-84%

DalalBaazaar Score

63/ 100

Good

Weighted across six categories. Every point is explained below.

✓ Beta of 0.00 — historically steadier than the index
✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ Profits have swung sharply from year to year — earnings are hard to forecast

Quality vs. Valuation

Company Quality

63/ 100

Average

How good the business is, ignoring the share price entirely.

Valuation

63/ 100

Fair

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

17.7x

3Y Median

39.7x

40 monthly readings · mean 40.7x · range 18.4x–69.2x

Sector Median

17.0x

median of 4 sector peers

🟢Current valuation is approximately 55% below its 3y median of 39.7x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟡Against its sector it is priced broadly in line with the peer median of 17.0x.

vs. its own history

Cheap

39.7x median over 40 months · -55%

vs. sector peers

Fair

17.0x median of 4 peers · +4%

vs. generic bands

Fair

15x–35x

EV/EBITDA

22.8x

PEG

—

What's Good / What's Bad

🟢 What's Going Well0

Nothing stands out as clearly improving on the years of data available.

🔴 What Needs Attention2

Return on equity is falling
ROE has dropped from 17.9% to 4.9% — each rupee of shareholder capital earns less than it did.
Return on capital is falling
ROCE has declined from 21.0% to 6.8% — often a sign of competition or overexpansion.

Red Flags

2 items require attention · 1 high · 1 watch

🔴Significant margin compressionFinancial
EBITDA margin has fallen 70.0 points, from 96.0% to 26.0%.
🟡Profit is decliningFinancial
Net profit is down 71% over 3 years.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Priced below its own history
The stock trades 55% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.

🔴 Bear CaseWhat could go wrong?

Margins are being competed away
EBITDA margin has fallen from 96.0% to 26.0%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
Returns on shareholder capital are falling
ROE has dropped from 17.9% to 4.9%. Each rupee of equity earns less than it did, so profit growth increasingly depends on raising more capital rather than on the existing base working harder.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 17% a year✓ 22.4% CAGR
Latest reported year was 2264.6%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 24%✓ 26.0%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Return on equity stays above 8%✗ 4.9%
For a lender this is the cleanest single read on whether the book is being grown profitably.
4Valuation vs its own median of 39.7x✓ 17.7x today
A re-rating above its own history needs a reason; without one it is just a higher price.

Investment Checklist

9 / 11 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✓ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

5 good · 4 neutral · 2 weak

Market Cap

₹47 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

17.7x

Fair

Fairly valued against the generic band

P/B Ratio

2.95x

Fair

Moderate premium to the company's book value

EPS (TTM)

₹2.56

Profitable

Profitable on a per-share basis

ROE

4.9%

Weak

Weak capital efficiency

ROCE

6.8%

Weak

Low return on total capital employed

Debt/Equity

0.19x

Low

Conservative leverage

Revenue Growth (YoY)

2264.6%

Healthy

Healthy top-line growth

Profit Growth (YoY)

1387.5%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

₹2 Cr

Cash generative

Generates cash even after funding its capex

More Metrics

Operating Margin

93.7%

Good

Healthy core-business profitability

Net Margin

27.7%

Good

Strong bottom-line conversion

Current Ratio

5.21

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.00

Defensive

Steadier than the market

52W Range Position

52%

Mid-range

Technical Snapshot

SMA 20 / SMA 50

45.7 / 44.0

Bullish alignment (short > long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

0.0

Oversold zone

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹4 Cr	₹3 Cr	₹0 Cr	₹7 Cr	+22.4%
EBITDA	₹3 Cr	₹2 Cr	-₹0 Cr	₹2 Cr	-20.8%
EBITDA Margin	96.0%	66.0%	-47.3%	26.0%	—
PAT (Net Profit)	₹3 Cr	₹1 Cr	-₹0 Cr	₹1 Cr	-33.6%
EPS	₹2.55	₹1.35	₹-0.06	₹0.75	-33.5%
ROE	17.9%	9.2%	-0.4%	4.9%	—
ROCE	21.0%	12.2%	-0.2%	6.8%	—
Free Cash Flow	₹3 Cr	₹1 Cr	₹0 Cr	₹2 Cr	-11.2%

🟢 Revenue has grown at 22.4% a year over 3 years.

🔴 EBITDA has shrunk at 20.8% a year over 3 years.

🔴 EBITDA Margin has fallen from 96.0% to 26.0% over 3 years (-70.0 pts).

🔴 PAT (Net Profit) has shrunk at 33.6% a year over 3 years.

🔴 EPS has shrunk at 33.5% a year over 3 years.

🔴 ROE has fallen from 17.9% to 4.9% over 3 years (-13.0 pts).

🔴 ROCE has fallen from 21.0% to 6.8% over 3 years (-14.3 pts).

🔴 Free Cash Flow has shrunk at 11.2% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹20 Cr

Total Liabilities

₹4 Cr

Total Debt

—

Cash & Equivalents

₹9 Cr

Operating Cash Flow

₹2 Cr

Capex

-₹0 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

98.9%

Corporate Actions

Ex-Dividend Date

05 Jul 2024

Peer Comparison

Company	P/E	ROE
BAJAJ FINANCE LIMITED	30.2x	17.8%
STATE BANK OF INDIA	10.3x	15.2%
HDFC BANK LTD	15.9x	13.8%
ICICI BANK LTD.	18.1x	16.5%

Recent News

2 mixed1 negative3 general

Top 15 Low-Price Stocks In India To Buy In October 2026

Samco, 17 Oct

HFCL share price jumps 4%. But can the rally last?

Value Research, 22 MayPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

SHAH INVESTOR'S HOME LTD. Stock/Share price , NSE/BSE Forecast News and Live Quotes

Equitymaster, 08 Oct

ICDS Ltd. (ICDSLTD) Share Price Surges 10% Amidst Market Activity

Univest, 28 JulPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Force Motors consolidated net profit declines 35.93% in the March 2026 quarter

Business Standard, 30 AprResults

🔴Potentially negativeReported deterioration, which feeds the growth and margin inputs on this page directly.

SpaceX falls below IPO price: How much of your money should be in futuristic tech?

Livemint, 23 Jun

Watch Items

This is a financial-sector business: borrowing is its raw material, not leverage in the usual sense. Debt/Equity and ROCE here aren't comparable to a manufacturer's — read them alongside NIM, GNPA and capital adequacy from the company's own disclosures.
Cross-check against the company's latest quarterly filing / investor presentation before acting.
RSI is in oversold territory — could mean either a bargain or a stock still falling for good reason. Check the 'why' before assuming reversal.

DalalBaazaar Thesis

StrongBusiness Quality · Financial Health · Valuation

MiddlingGrowth · Profitability

WeakRisk

Points for each in the Score ↑

Unremarkable in both directions

A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 1 high-severity red flag sits above this conclusion and should be read first.

1 of 4 tripwires tripped — Return on equity stays above 8% · see Key things to watch ↑